Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2026-05-12 @ 2:08 PM
Study NCT ID:
NCT00574769
Status:
COMPLETED
Last Update Posted:
2017-04-11
First Post:
2007-12-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer
Sponsor:
University of Southern California
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Prostate Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | RAD001 | View |
| None | mTOR inhibition | View |
| None | docetaxel | View |
| None | bevacizumab | View |
| None | adenocarcinoma of the prostate | View |
| None | recurrent prostate cancer | View |
| None | stage IV prostate cancer | View |
| None | prostate cancer | View |
| None | Metastatic, androgen independent prostate cancer | View |